肥胖者增多，推动美国冠状动脉支架市场

htchb

Rising Obesity Rates Drive the U.S. Coronary Stent Market

美国肥胖者增多，推动美国冠状动脉支架市场

Date Published: 14 Aug 2007

出版日期：2007年8月14日

Palo Alto, Calif. – August 14, 2007 – Sky rocketing obesity rates in certain segments of the population are heightening the demand for efficient percutaneous coronary intervention (PCI). High patient volumes have increased the clinical preference for simple outpatient PCI procedures over more complicated open heart procedures. The premier product in PCI therapy is the drug eluting stent.

加利福尼亚Palo Alto-2007年8月14日-飞速上升的美国肥胖者占美国人口相当一部分，这提高了有效经皮冠状动脉介入的需求。大量病人优先选择简单的门诊经皮冠状动脉介入操作，已经超过复杂开胸操作。经皮冠状动脉介入操作最主要结果是药物冲洗支架。

New analysis from Frost & Sullivan (http://www.medicaldevices.frost.com), U.S. Coronary Stent Market, reveals that the market earned revenues of $3.27 billion in 2006 and estimates this to reach $4 billion in 2013.

美国冠状动脉支架市场Frost 和 Sullivan最新分析显示2006年市场盈利是32.7亿美元，估计在2013年达到40亿美元。

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants an overview of the latest analysis of the U.S. Coronary Stent Market, then send an e-mail to Melina Trevino - Corporate Communications at melina.trevino@frost.com with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. We will send you the information via email upon receipt of the above information.

如果你对实际记录册感兴趣，这可以提供最新分析的美国冠状动脉支架市场厂商，最终用户及其它参与企业的概况，然后你发送邮件到melina.trevino@frost.com，内容包含你的全名，公司名，标题，电话号码，e-mail地址，所在国家，城市等信息来联系 Melina Trevino社团通讯系统。

“Although only introduced in 2003, drug eluting stents reshaped the entire cardiovascular industry in a few short years. It made bypass procedures and their technologies nearly outmoded,” says Frost & Sullivan Research Analyst Venkat Rajan. “By 2005 nearly 90 percent of all stents being implanted were drug eluting devices over bare metal devices.”

Frost &和Sullivan研究分析员讲 ：“虽然药物冲洗支架技术在2003年才引进，但是它在短短的几年内开创了心血管行业新局面。它几乎使分流操作及技术过时了。”“到2005年几乎90%植入的支架是药物洗脱设备，而不是单纯的金属设备。”

There is a higher concentration of high obesity populations in poorer areas. Economists point to the relatively lesser price of high calorie high fat foods, and the high cost of
diets composed of whole grains, fish, and fresh vegetables and fruit. Results from a national survey on childhood obesity show that over 17 percent of adolescent ages 2-19 years are overweight. Obesity at such a young age accelerates the onset of type II diabetes, due to which the risks of a major cardiovascular event are amplified. The future of advanced cardiovascular care is facing a customer base with heightened demand, but a diminished capacity to pay for high end technologies.

比较贫困地区有较多的肥胖人口集中。经济学家指出高热量，高脂肪食物，以及由全部的谷类，鱼及新鲜蔬菜水果组成的高消费饮食会付出相对少得代价。对儿童肥胖的国际调查结果显示2—19岁年龄段青少年有超过17%的人超重。如此年少的青少年肥胖加快了II型糖尿病发病，由此主要心血管事件的危险性增大了。先进的心血管护理的未来将面对高需求但支付高端技术能力下降的消费者基础。

In the coronary stent market, there are the entrenched market leaders, and those knocking on the door hoping to grab a share of this $3.2 billion market. The next several years will see new product launches from other competitors such as Medtronic, Guidant, Abbott Laboratories, and in the long term even possibly niche manufacturers able to take their device to market. Even current market participants; such as, Boston Scientific with its Taxus Liberte and Cordis/ J&J with its Cypher Select are developing second
generations of their popular devices.

在冠状动脉支架市场，有防卫市场的领导们及那些试图抢进市场共享32亿美元的交易者们。以后的几年将会有来自其它竞争者例如Medtronic, Guidant, Abbott公司开创的新产品，从长远来讲，niche生产商把他们的设备带进市场也成为可能。甚至现在的市场参与者，例如Boston Scientific及它的Taxus Liberte和Cordis/ J&J 及Cypher Select正在开发他们普及设备的第二代。

\"The majority of clinicians who are satisfied with the performance of the stents they are currently using, will lack incentive to incorporate a new device into their practice,\" explains Rajan. \"Only a device with a novel approach and significant clinical benefit over
existing products will be capable of achieving high levels of initial market growth.\"

Rajan 解释说：“对现使用支架效能满意的大部分临床医生将会缺乏动力应用一个新的设备到临床。只有比现在产品有创新及明显临床效益的设备才能够达到高水平的初始市场增长。”

With the surge in patient demand, it is important to perform procedures that are quick, cost effective, and require the least amount of additional hospital attention. PCI procedures are routine. They involve minimal scarring and have quick recovery
times. Therefore, they will be the predominant therapy of choice in revascularization in the near and long term market future.

随着病人需求的增长，快速，有效，需要最少医院额外注意的操作是很重要的。PCI是一个常规操作。它们带来很小的疤痕并且可以快速恢复。因此，在不久及长远的将来，PCI将会是血管形成术选择中主要的治疗手段。

U.S. Coronary Stent Market is part of the Medical Devices
Growth Partnership Service, and it provides an overview of the trends and technologies that have shaped market revenues, market share, and implantation rates in the individual segments of the market. In this research, Frost & Sullivan's expert
analysts thoroughly examine the drug eluting and bare metal stents markets along with the coronary care trends in the U.S. Interviews with the press are available.

美国冠状动脉支架市场是医学用具成长合伙部门的一部分，它提供市场发展趋势，技术的概况，这已经促使市场单一部门的市场盈利，市场股份，及植入率有了发展。在这个研究中，Frost 及Sullivan的专业分析员仔细的监测了药物冲洗及单纯金属支架市场连同美国的冠状动脉护理趋势。采访新闻记者是可以的。（2007年8月14日）